Search research articles
Contact Us
Filters
Showing results (51-60 of 105) with videos related to
Page
of 11
Sort By:
Immunotherapy
|
January 21, 2021
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases
Vincenzo Di Nunno, Giacomo Nuvola, Mirta Mosca, et al.
British Journal of Haematology
|
March 5, 2003
Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes
Renato Zambello, Livio Trentin, Monica Facco, et al.
Advances in Therapy
|
December 2, 2021
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Cells
|
January 11, 2024
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, et al.
Diagnostics (Basel, Switzerland)
|
October 23, 2021
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
Ilaria Maggio, Enrico Franceschi, Vincenzo Di Nunno, et al.
Frontiers in Oncology
|
April 16, 2026
Glioblastoma and PARP inhibitors: the importance of patient selection to maximize therapeutic benefits. A critical review
Giovanni Dima, Vincenzo Di Nunno, Marta Aprile, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2021
Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study
Alicia Tosoni, Lidia Gatto, Enrico Franceschi, et al.
Cancer
|
June 11, 2009
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2004
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
Alba A Brandes, Alicia Tosoni, Umberto Basso, et al.
Neuro-Oncology
|
May 26, 2006
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma
Alba A Brandes, Linda Nicolardi, Alicia Tosoni, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 105) with videos related to
Sort By:
Page
of 11
Immunotherapy
|
January 21, 2021
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases
Vincenzo Di Nunno, Giacomo Nuvola, Mirta Mosca, et al.
British Journal of Haematology
|
March 5, 2003
Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes
Renato Zambello, Livio Trentin, Monica Facco, et al.
Advances in Therapy
|
December 2, 2021
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Cells
|
January 11, 2024
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, et al.
Diagnostics (Basel, Switzerland)
|
October 23, 2021
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
Ilaria Maggio, Enrico Franceschi, Vincenzo Di Nunno, et al.
Frontiers in Oncology
|
April 16, 2026
Glioblastoma and PARP inhibitors: the importance of patient selection to maximize therapeutic benefits. A critical review
Giovanni Dima, Vincenzo Di Nunno, Marta Aprile, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2021
Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study
Alicia Tosoni, Lidia Gatto, Enrico Franceschi, et al.
Cancer
|
June 11, 2009
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2004
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
Alba A Brandes, Alicia Tosoni, Umberto Basso, et al.
Neuro-Oncology
|
May 26, 2006
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma
Alba A Brandes, Linda Nicolardi, Alicia Tosoni, et al.
Page
of 11